Description
Despite more widespread availability of the COVID-19 vaccine, many patients still express concerns about the safety of the vaccine, given how quickly it was approved. This session seeks to provide an overview of the clinical trials process, followed by a deeper dive into the COVID-19 trials specifically. Discussion of the COVID-19 vaccine trials will include information on the timelines, enrollment statistics, and safety and efficacy data. Finally, several patient concerns about the COVID-19 vaccine will be explored, as well as strategies to address them. This session will help you provide more information to your patients on the development and approval of the COVID-19 vaccine and tactics to combat vaccine hesitancy.